Technetium TC-99M Pyrophosphate Kit Injection Shortage: Supply Updates and Manufacturer Status
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
The FDA reports a current shortage of Technetium TC-99M Pyrophosphate Kit Injection, a medical imaging agent, with manufacturers expecting supply recovery in 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on February 11, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Drug Shortages — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Technetium TC-99M Pyrophosphate) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What's in Shortage
Technetium TC-99M Pyrophosphate Kit Injection is currently listed as in shortage. This medication is used within the therapeutic category of Medical Imaging. It is available under the brand names TECHNESCAN PYP and KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE. The current status of this medication is listed as "Current" on the FDA shortage database.
Which Manufacturers Are Affected
Currently, all listed manufacturers report that the product is unavailable, with supply recovery not expected until 2026.
Curium US LLC
- Status: Unavailable
- Note: Supply anticipated in Q1 2026
- Presentation: Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)
- Contact: 888-744-1414
Sun Pharmaceutical Industries, Inc.
- Status: Unavailable
- Note: New supply anticipated in Q2 2026
- Presentation: CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1 and 45567-0060-2)
- Contact: 800-818-4555
Why There's a Shortage
The reason provided for this shortage is a shortage of an active ingredient necessary for the production of the injection.
What Patients Should Do
If you are scheduled for medical imaging that requires Technetium TC-99M Pyrophosphate, please take the following steps:
- Consult Your Healthcare Provider: Discuss the shortage with your doctor or the medical imaging department to understand how this affects your procedure.
- Contact the Manufacturer: You may use the contact information provided above to inquire about the most recent supply updates directly from the manufacturers.
- Speak with a Pharmacist: Your pharmacist may have information regarding institutional availability or local supply status.
Disclaimer: Patients should always consult their healthcare provider regarding medical decisions. Do not make changes to your medical care without professional consultation.
Source
Attribution: FDA Drug Shortage Database
- Initial Posting Date: 12/27/2023
- Last Updated: 02/04/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.
What is this FDA drug-shortage notice about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Drug Shortages updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category